---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-21-020237"
form_type: "8-K"
ticker: "XFOR"
cik: "0001501697"
company_name: "X4 Pharmaceuticals, Inc"
filed_at: "2021-10-19T23:59:59+00:00"
generated_at: "2026-06-28T19:57:55.748389+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# X4 Pharmaceuticals appoints Francoise de Craecker to Board and Compensation Committee

## Summary
- Francoise de Craecker appointed as Class III director effective Oct 14, 2021, term through 2023 annual meeting.
- She replaces Alison Lawton on the Compensation Committee; Lawton remains on the Board.
- Received initial option to purchase 12,250 shares vesting over three years, with full acceleration on change of control.
- Compensation follows standard non-employee director policy as described in the 2021 proxy statement.

## SEC filing metadata
- accession: 0001628280-21-020237
- form_type: 8-K
- ticker: XFOR
- cik: 0001501697
- company_name: X4 Pharmaceuticals, Inc
- filed_at: 2021-10-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501697/000162828021020237/0001628280-21-020237-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501697/000162828021020237/xfor-20211014.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-21-020237
- JSON: https://secwatch.observer/filing/0001628280-21-020237.json
- Plain text: https://secwatch.observer/filing/0001628280-21-020237.txt

## Key facts
- Executive change
  Francoise de Craecker was appointed as Director at X4 Pharmaceuticals, Inc.
  - Action: appointed
  - Role: Director
  source text: On October 14, 2021, the Board of Directors (the “Board”) of X4 Pharmaceuticals, Inc. (the “Company”) appointed Francoise de Craecker as a member of the Company’s Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1501697/000162828021020237/0001628280-21-020237-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.